Glousker Galina, Touzot Fabien, Revy Patrick, Tzfati Yehuda, Savage Sharon A
Department of Genetics, The Silberman Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem, Israel.
INSERM UMR 1163, Laboratory of Genome Dynamics in the Immune System, Paris Descartes - Sorbonne Paris Cité University, Imagine Institute, Paris, France.
Br J Haematol. 2015 Aug;170(4):457-71. doi: 10.1111/bjh.13442. Epub 2015 May 4.
Hoyeraal-Hreidarsson (HH) syndrome is a multisystem genetic disorder characterized by very short telomeres and considered a clinically severe variant of dyskeratosis congenita. The main cause of mortality, usually in early childhood, is bone marrow failure. Mutations in several telomere biology genes have been reported to cause HH in about 60% of the HH patients, but the genetic defects in the rest of the patients are still unknown. Understanding the aetiology of HH and its diverse manifestations is challenging because of the complexity of telomere biology and the multiple telomeric and non-telomeric functions played by telomere-associated proteins in processes such as telomere replication, telomere protection, DNA damage response and ribosome and spliceosome assembly. Here we review the known clinical complications, molecular defects and germline mutations associated with HH, and elucidate possible mechanistic explanations and remaining questions in our understanding of the disease.
霍耶拉尔-赫雷达尔松(HH)综合征是一种多系统遗传性疾病,其特征为端粒极短,被认为是先天性角化不良的一种临床严重变异型。死亡的主要原因通常是骨髓衰竭,多发生在儿童早期。据报道,几个端粒生物学基因的突变在约60%的HH患者中导致该病,但其余患者的基因缺陷仍不清楚。由于端粒生物学的复杂性以及端粒相关蛋白在端粒复制、端粒保护、DNA损伤反应以及核糖体和剪接体组装等过程中发挥的多种端粒和非端粒功能,了解HH的病因及其多样表现具有挑战性。在此,我们综述了与HH相关的已知临床并发症、分子缺陷和种系突变,并阐明了在我们对该疾病的理解中可能的机制解释和尚存的问题。